Over its short history, since commencing operations in 2007, the company has become a powerhouse for drug and new product development and manufacture, with equal emphasis on biological and chemical-based products and services.
A team of experienced chemists, biologists and engineers own the responsibility of transparent and ethical dealing with customers. Anthem’s labs have helped new and established biotechs and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and much more.
In addition to product research and development, Anthem helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, Antibody Drug Conjugates, R&D and manufacture of highly potent compounds, flow chemistry based production and large scale commercial product manufacture. Anthem has been successfully inspected by USFDA, PMDA (Japan), and EU QPs.
Anthem has leveraged its core competency in organic synthesis to develop new and challenging nutritional products with a strong scientific rationale. These are now being sold globally to nutraceutical and wellness product companies.
Anthem backs up its top-flight R&D capabilities with one of the best in class Quality Control and Analytical development capabilities. In addition to optimizing manufacturing schemes, Anthem has helped its clients develop GMP analytical testing methods, characterization and testing, reference standards preparation, stability studies and much more for impurities, intermediates and products. Regulatory compliance, Quality Assurance and CMC documentation experts assist clients to bring research products to market.
With its second-to-none infrastructure Anthem, Biosciences can do GMP synthesis ranging from milligram to kilogram, multi-kilogram to multiple ton scale. Apart from modern well-equipped labs, the company has a cGMP kilo lab and a versatile GMP pilot plant.